Last reviewed · How we verify
NCT07078123
Hydrocelectomies in Male Donors
trial testing Laparoscopic Donor Nephrectomy in Hydrocele in 2,750 participants. Completed in 31 March 2021.
31 March 2020
Quick facts
| Lead sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,750 |
| Start date | 1 April 2002 |
| Primary completion | 31 March 2020 |
| Estimated completion | 31 March 2021 |
Drugs / interventions tested
- Laparoscopic Donor Nephrectomy
Conditions studied
- Hydrocele — all drugs for Hydrocele →
- Hydrocele of Tunica Vaginalis — all drugs for Hydrocele of Tunica Vaginalis →
- Hydrocelectomy — all drugs for Hydrocelectomy →
- Living Kidney Donor — all drugs for Living Kidney Donor →
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Who can join
Adults 18 to 106, male only, with Hydrocele or Hydrocele of Tunica Vaginalis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a population-based matched cohort study to examine whether male living kidney donors are at increased risk of undergoing hydrocelectomy compared to similar males in the general population. Using linked health administrative data from Alberta, Canada, male donors who underwent laparoscopic nephrectomy between 2002 and 2020 will be matched 1:10 to non-donors based on key demographic and clinical characteristics. Males will be followed for several years, from the time of cohort entry through the datasets until March 2021. The primary outcome is a hospital admission for hydrocelectomy in the follow-up period. The secondary outcome is receipt of a scrotal ultrasound.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07078123
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials
Trials by the same sponsor.
- NCT07588711 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Neuropathic Pain Following Spinal Cord Injury · NA · not yet recruiting
- NCT07585292 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Musculoskeletal Pain in Cerebral Palsy · NA · not yet recruiting
- NCT07510906 — Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer · NA · not yet recruiting
- NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
- NCT06035809 — Sensory Motor Arousal Regulation Treatment (SMART) Study · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07078123 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Last refreshed: 22 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07078123.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing